The number of people with susceptibility test result for rifampicin in Egypt
Egypt: The number of people with susceptibility test result for rifampicin was 89 in 2021. ▲ Rising
Latest (2021)
89
Change on year
up 4.7%
World rank
71st
of 146 countries
All-time high
91.35
in 2019
All-time low
16.36
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Egypt, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Egypt stood at 89.
The figure is up 4.7% on the previous year and up 444.0% over five years.
Egypt ranks 71st of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Egypt, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 16.36 | — |
| 2018 | 90.31 | +452.1% |
| 2019 | 91.35 | +1.2% |
| 2020 | 85.02 | -6.9% |
| 2021 | 89 | +4.7% |
Egypt compared with similar countries
- Egypt's 89 is above the median for lower middle income countries, which is 78.77, 1.1× the median. (32 countries reporting)
- Egypt's 89 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 89, 1.0× the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 66.01 | 16.36 | 91.35 | 3 |
| 2020s | 87.01 | 85.02 | 89 | 2 |
Countries ranked near Egypt
More health data for Egypt
- Un projection of annual infant deaths, annual growth rate -1.46 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7884 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 946 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7,225 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.3993 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0487 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4524 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Egypt?
- The number of people with susceptibility test result for rifampicin in Egypt was 89 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Egypt?
- The highest recorded value was 91.35 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Egypt?
- The lowest recorded value was 16.36 in 2017.
- How does Egypt rank for the number of people with susceptibility test result for rifampicin?
- Egypt ranks 71st out of 146 countries with data for 2021.
- Where does this Egypt data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).